Targeting the androgen receptor in hormone-refractory prostate cancer--new concepts (Q36429396)

14 August 2017

1 reference

title

Targeting the androgen receptor in hormone-refractory prostate cancer--new concepts (English)

1 reference

14 August 2017

1 reference

Iris E Eder

1

1 reference

14 August 2017

Petra Haag

series ordinal

2

1 reference

14 August 2017

Georg Bartsch

series ordinal

3

1 reference

14 August 2017

Helmut Klocker

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

14 August 2017

1 reference

14 August 2017

1

1 reference

14 August 2017

1

1 reference

14 August 2017

93-101

1 reference

Decreasing mortality rates for prostate cancer: possible role of hormonal therapy?

14 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

The androgen receptor gene mutations database (ARDB): 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

The androgen axis in recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Pharmacodynamics of selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Repression of androgen-regulated gene expression by dominant negative androgen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Approaches for the sequence-specific knockdown of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Specific block of androgen receptor activity by antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Chemosensitization of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.91

21 January 2018

Identifiers

DOI

10.1517/14796694.1.1.91

1 reference

14 August 2017

1 reference